NCT04267848 2026-04-17
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
Phase 3 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
Innovent Biologics (Suzhou) Co. Ltd.
Radiation Therapy Oncology Group
Merck Sharp & Dohme LLC
EQRx International, Inc.
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)